11. LEASES

We currently lease our research and office space under a noncancelable lease agreement with our landlord, Healthpeak Properties, Inc. (formerly known as HCP BTC, LLC), which was originally set to expire in 2018. The lease term provides for renewal option for up to two additional periods of five years each. In July 2017, we exercised our option to extend the term of our lease for another five years through January 2023 and modified the amount of monthly base rent during such renewal period.

​

In December 2014, we entered into a sublease agreement, which was amended in 2017, with an unrelated third party to occupy approximately 57,000 square feet of our research and office space. In February 2017, we entered into an amendment to the sublease agreement to increase the subleased research and office space for an additional 9,328 square feet under the same term of the sublease. Effective July 2017, the sublease agreement was amended primarily to extend the term of the sublease through January 2023 and modified the monthly base rent to equal the amount we will pay our landlord. Because the future sublease income under the extended sublease agreement is the same as the amount we will pay our landlord, we did not recognize any loss on sublease relative to this amendment. As of December 31, 2021, we expect to receive approximately $5.1 million in future sublease income (excluding our subtenant’s share of facilities operating expenses) through January 2023.

​

As of December 31, 2021 and 2020, we had operating lease right-of-use asset of $9.7 million and $17.9 million, respectively, and lease liability of $10.7 million and $19.3 million, respectively, in the balance sheet. The weighted average remaining term of our lease as of December 31, 2021 was 1.08 years.

​

As of December 31, 2021, we received from our landlord leasehold improvement incentives amounting to $0.6 million related to leasehold improvements. We record these leasehold improvement incentives as a reduction to operating lease right-of-use asset and lease liability until the lease ends and the asset is transferred.

​

We recorded rent expense on a straight-line basis for our lease, net of sublease income. For our sublease arrangement which we classified as an operating lease, our loss on the sublease was comprised of the present value of our future payments to our landlord less the present value of our future rent payments expected from our subtenant over the term of the sublease.

The components of our operating lease expense for the periods presented were as follows (in thousands):

​

​

Supplemental information related to the Company’s operating lease for the periods presented were as follows (in thousands):

​

We have the following operating sublease information for the periods presented (in thousands):

​

​

As of December 31, 2021, future minimum lease payments and obligations under our noncancelable operating lease, net of expected sublease receipts, were as follows (in thousands):

​

​

Rent expense under our operating lease amounted to approximately $6.3 million, $6.3 million and $6.0 million for the years ended December 31, 2021, 2020 and 2019, respectively.